Rockefeller Capital Management’s Xtant Medical Holdings XTNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-120
Closed 4439
2022
Q2
$0 Hold
120
﹤0.01% 4429
2022
Q1
$0 Hold
120
﹤0.01% 4091
2021
Q4
$0 Hold
120
﹤0.01% 4016
2021
Q3
$0 Hold
120
﹤0.01% 3872
2021
Q2
$0 Hold
120
﹤0.01% 3628
2021
Q1
$0 Hold
120
﹤0.01% 3412
2020
Q4
$0 Hold
120
﹤0.01% 3025
2020
Q3
$0 Hold
120
﹤0.01% 2833
2020
Q2
$0 Hold
120
﹤0.01% 2706
2020
Q1
$0 Hold
120
﹤0.01% 2502
2019
Q4
$0 Buy
+120
New +$246 ﹤0.01% 2234

Other funds holding XTNT

Rockefeller Capital Management's XTNT Position: Q3 2022 in Review

Rockefeller Capital Management sold out of Xtant Medical Holdings (XTNT) in Q3 2022, closing a stake of 120 shares.

Rockefeller Capital Management first reported a position in XTNT in Q4 2019 and held it in 11 quarters. The position peaked at $0 in Q2 2022. 18 funds tracked by Wall St. Rank hold XTNT as of Q3 2022.

  • Rockefeller Capital Management reported no remaining Xtant Medical Holdings position as of Q3 2022 after selling out during the quarter.
  • Rockefeller Capital Management sold 120 Xtant Medical Holdings shares in Q3 2022.
  • Rockefeller Capital Management first reported a position in Xtant Medical Holdings in Q4 2019 and held it in 11 quarters.
  • Rockefeller Capital Management's Xtant Medical Holdings position peaked at $0 in Q2 2022.
  • 18 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q3 2022.

Based on Rockefeller Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.